Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Periplakin is a target for autoimmunity in asthma

Fig. 1

Western blot analysis of anti-periplakin (PPL) antibodies (Abs) of IgE isotype (I) and IgG isotype (II) in 6 patients. Lane 1, molecular weight; lanes 2–4, 3 patients with mild to moderate asthma; lanes 5–7, 3 patients with severe asthma; lane 8, healthy control; lane 9, polyclonal anti-PPL Ab (sc-16754, Santa Cruz Biotechnology)

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us